Litigation, Patent
Promise Doctrine Rejected by the Supreme Court of Canada
On June 30, 2017, the Supreme Court of Canada released its highly anticipated landmark decision in AstraZeneca Canada Inc. v. Apotex Inc. (
2017 SCC 36) in which it considered the so-called “promise doctrine”. The Supreme Court of Canada has found the “promise doctrine” to be “unsound”, “not good law” and “incongruent with both the words and scheme of the Patent Act.”
Read More